Learn

Saturday, 21 November

FMGE · blueprint and recall

FMGE Chemotherapy

Seen in 17 of the 19 sessions with recall; 11 of the 11 well-covered sessions.

Concepts in recalled topics
37
unofficial
Outline topics seen
8
Other tested areas
0
Outline topics unseen
0

Recurrence and coverage

A session counts once even when several concepts were recalled. Thinly covered sessions and well-covered sessions are shown separately.

Seen in 17 of the 19 sessions with recall; 11 of the 11 well-covered sessions.

First seen: FMGE Jun 2009. Last seen: FMGE Jan 2026.

First and last seen describe this collection only. The official blueprint assigns 13 questions to Pharmacology; it does not assign an official question count to this Lumi chapter. Read the method.

Outline topics seen in recall

Ranked by recalled sessions. Each topic shows both recurrence counts, first and last seen, and styles.

  • Chemotherapy

    Anticancer drugs

    Seen in 14 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jan 2026.

    Styles: one-liner (10) · vignette (3).

  • Chemotherapy

    Antimalarials and anthelmintics

    Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (4) · vignette (1).

  • Chemotherapy

    Fluoroquinolones and others

    Seen in 5 of the 19 sessions with recall; 4 of the 11 well-covered sessions.

    First seen: FMGE Dec 2010. Last seen: FMGE Jul 2025.

    Styles: one-liner (6) · vignette (1).

  • Chemotherapy

    Antifungals

    Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Jun 2011. Last seen: FMGE Jul 2025.

    Styles: one-liner (1) · vignette (1).

  • Chemotherapy

    Antivirals

    Seen in 3 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Dec 2020.

    Styles: one-liner (3) · image + vignette (1).

  • Chemotherapy

    Aminoglycosides, macrolides and tetracyclines

    Seen in 3 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Dec 2011. Last seen: FMGE Jan 2025.

    Styles: one-liner (3).

  • Chemotherapy

    Beta-lactams

    Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Jun 2019. Last seen: FMGE Aug 2020.

    Styles: one-liner (1) · vignette (1).

  • Chemotherapy

    Antitubercular and antileprotic drugs

    Seen in 1 of the 19 sessions with recall; 0 of the 11 well-covered sessions.

    First seen: FMGE Dec 2010. Last seen: FMGE Dec 2010.

    Styles: one-liner (1).

Other tested areas

Areas recorded in the recall that sit outside Lumi's topic outline. They are kept here so the chapter's coverage stays visible.

No additional areas recorded outside the outline.

Outline topics not yet seen

No recorded recall in this collection. This does not mean the topic has never been tested.

Every outline topic in this chapter has recorded recall.

Question styles and image links

Question styles in the recall

one-liner
29 concepts · 78.4%
vignette
7 concepts · 18.9%
image + vignette
1 concepts · 2.7%